BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 19225145)

  • 1. Cellular mediators of renal vascular dysfunction in hypertension.
    Ponnuchamy B; Khalil RA
    Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R1001-18. PubMed ID: 19225145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and mediators of the vascular dysfunction associated with hypertension in pregnancy.
    Sheppard SJ; Khalil RA
    Cardiovasc Hematol Disord Drug Targets; 2010 Mar; 10(1):33-52. PubMed ID: 20041838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage.
    Mennuni S; Rubattu S; Pierelli G; Tocci G; Fofi C; Volpe M
    J Hum Hypertens; 2014 Feb; 28(2):74-9. PubMed ID: 23803592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular and cellular calcium in normal and hypertensive pregnancy.
    Adamova Z; Ozkan S; Khalil RA
    Curr Clin Pharmacol; 2009 Sep; 4(3):172-90. PubMed ID: 19500073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammatory cytokines in vascular dysfunction and vascular disease.
    Sprague AH; Khalil RA
    Biochem Pharmacol; 2009 Sep; 78(6):539-52. PubMed ID: 19413999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal autoregulation in health and disease.
    Carlström M; Wilcox CS; Arendshorst WJ
    Physiol Rev; 2015 Apr; 95(2):405-511. PubMed ID: 25834230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal vascular dysfunction precedes the development of renal damage in the hypertensive Fawn-Hooded rat.
    Ochodnický P; Henning RH; Buikema HJ; de Zeeuw D; Provoost AP; van Dokkum RP
    Am J Physiol Renal Physiol; 2010 Mar; 298(3):F625-33. PubMed ID: 20007352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of high salt intake on endothelial function: reduced vascular nitric oxide in the absence of hypertension.
    Boegehold MA
    J Vasc Res; 2013; 50(6):458-67. PubMed ID: 24192502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered myogenic vasoconstriction and regulation of whole kidney blood flow in the ASIC2 knockout mouse.
    Gannon KP; McKey SE; Stec DE; Drummond HA
    Am J Physiol Renal Physiol; 2015 Feb; 308(4):F339-48. PubMed ID: 25520010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure to vasodilate in response to salt loading blunts renal blood flow and causes salt-sensitive hypertension.
    Wu J; Agbor LN; Fang S; Mukohda M; Nair AR; Nakagawa P; Sharma A; Morgan DA; Grobe JL; Rahmouni K; Weiss RM; McCormick JA; Sigmund CD
    Cardiovasc Res; 2021 Jan; 117(1):308-319. PubMed ID: 32428209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiology of essential hypertension: role of the pump, the vessel, and the kidney.
    Cain AE; Khalil RA
    Semin Nephrol; 2002 Jan; 22(1):3-16. PubMed ID: 11785064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular and vascular targets in the pathogenesis and management of the hypertension associated with preeclampsia.
    Reslan OM; Khalil RA
    Cardiovasc Hematol Agents Med Chem; 2010 Oct; 8(4):204-26. PubMed ID: 20923405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelial dysfunction: from physiology to therapy.
    Mombouli JV; Vanhoutte PM
    J Mol Cell Cardiol; 1999 Jan; 31(1):61-74. PubMed ID: 10072716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial factors in the pathogenesis and treatment of chronic kidney disease Part I: General mechanisms: a joint consensus statement from the European Society of Hypertension Working Group on Endothelin and Endothelial Factors and The Japanese Society of Hypertension.
    Rossi GP; Seccia TM; Barton M; Danser AHJ; de Leeuw PW; Dhaun N; Rizzoni D; Rossignol P; Ruilope LM; van den Meiracker AH; Ito S; Hasebe N; Webb DJ
    J Hypertens; 2018 Mar; 36(3):451-461. PubMed ID: 29120962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactive oxygen species: roles in blood pressure and kidney function.
    Wilcox CS
    Curr Hypertens Rep; 2002 Apr; 4(2):160-6. PubMed ID: 11884272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dysfunctional renal nitric oxide synthase as a determinant of salt-sensitive hypertension: mechanisms of renal artery endothelial dysfunction and role of endothelin for vascular hypertrophy and Glomerulosclerosis.
    Barton M; Vos I; Shaw S; Boer P; D'Uscio LV; Gröne HJ; Rabelink TJ; Lattmann T; Moreau P; Lüscher TF
    J Am Soc Nephrol; 2000 May; 11(5):835-845. PubMed ID: 10770961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial dysfunction and vascular disease - a 30th anniversary update.
    Vanhoutte PM; Shimokawa H; Feletou M; Tang EH
    Acta Physiol (Oxf); 2017 Jan; 219(1):22-96. PubMed ID: 26706498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating and Vascular Bioactive Factors during Hypertension in Pregnancy.
    Tanbe AF; Khalil RA
    Curr Bioact Compd; 2010 Mar; 6(1):60-75. PubMed ID: 20419111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox signaling in hypertension.
    Paravicini TM; Touyz RM
    Cardiovasc Res; 2006 Jul; 71(2):247-58. PubMed ID: 16765337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioactive factors in uteroplacental and systemic circulation link placental ischemia to generalized vascular dysfunction in hypertensive pregnancy and preeclampsia.
    Shah DA; Khalil RA
    Biochem Pharmacol; 2015 Jun; 95(4):211-26. PubMed ID: 25916268
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.